Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01718262 · ClinicalTrials.gov registry record
Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion
A clinical trial, sponsored by Defense and Veterans Center for Integrative Pain Management.
- Completed
- Registry status
- 49
- Enrollment target
NCT01718262 is a clinical trial that has completed, run by Defense and Veterans Center for Integrative Pain Management. The registered enrollment target is 49 participants.
The verdict
NCT01718262 has completed, sponsored by Defense and Veterans Center for Integrative Pain Management.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The purpose of the study is to measure the blood levels of the medicine called ropivacaine (local anesthetic) used to manage pain. Ropivacaine is a widely used medication and is not the subject of this study, but the investigators are studying how much of the drug can be found in the patient's blood, known as the blood level, of this medicine. Too much ropivacaine in a patient's blood can lead to local anesthetic toxicity. Once the nerve catheter is removed, local anesthetic toxicity is no longer a potential problem. However, there is little data on what ropivacaine blood levels are after having the catheter in for a long period of time(up to one month).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01718262
The ClinicalTrials.gov registry entry for NCT01718262 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Defense and Veterans Center for Integrative Pain Management, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01718262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01718262 about?
NCT01718262 is a clinical study titled "Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion". The purpose of the study is to measure the blood levels of the medicine called ropivacaine (local anesthetic) used to manage pain. Ropivacaine is a widely used medication and is not the subject of this study, but the investigators are studying how much of the drug can be found in the patient's blood...
What is the current status of trial NCT01718262?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2010-04. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT01718262?
This trial is sponsored by Defense and Veterans Center for Integrative Pain Management, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.